Plain-English translation of NCT06151834 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new implant called Kerifuse, which is designed to help treat severe arthritis in the small joints at the ends of your fingers. The implant works by fusing together the damaged joint so it stops moving and causing pain. Researchers want to measure how quickly the bone heals and how satisfied patients are with the results.
Finger arthritis can be very painful and limit what you can do with your hands. While surgery to fuse these joints has been done for years using different methods, this trial exists to see if the Kerifuse implant offers better results, faster healing, and fewer side effects than other approaches currently available.
You likely qualify if…
You likely don't qualify if…
You would undergo surgery to have the Kerifuse implant placed in your arthritic finger joint. After surgery, you would return for follow-up visits where doctors will check how well your bone is healing using X-rays and will ask you about your pain level, hand function, and satisfaction with the results. The study will track your recovery over time to see how quickly the implant allows your joint to fuse and heal.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
France
Sponsor
Clinique Saint François, Nice, France
Enrollment target
~50 participants
Started
December 2023
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Nicolas DREANT, MD
Clinique Saint François, Nice, France
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.